TriRx Huntsville Pharmaceutical Services, LLC

Form 483 issued April 1, 2022 · Huntsville, Alabama

Inspection
Mar 22 – Apr 1, 2022
Investigator
Brittny C. Cargo
Observations
2
Pages
5
FEI number
3003197096

In short: On April 1, 2022, FDA issued a Form 483 with 2 observations to TriRx Huntsville Pharmaceutical Services, LLC in Huntsville, Alabama (FEI 3003197096) after an inspection that ran Mar 22 – Apr 1, 2022. The investigator was Brittny C. Cargo. Most observations concern production and quality system.

At a glance

Production and quality system account for 2 of 2 observations.

Production1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent objectionable microorganisms in drug products not required to be…

  2. 02

    The responsibilities and procedures applicable to the quality control unit are not in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at TriRx Huntsville Pharmaceutical Services, LLC?

FDA listed 2 observations on this Form 483, mostly about production and quality system. The opening words of each observation are shown on this page.

Who inspected TriRx Huntsville Pharmaceutical Services, LLC?

Brittny C. Cargo is named on this Form 483, for the inspection of Mar 22 – Apr 1, 2022. Each investigator has a profile showing what they cite most.

When was TriRx Huntsville Pharmaceutical Services, LLC inspected by FDA?

The inspection ran Mar 22 – Apr 1, 2022, and the Form 483 is dated April 1, 2022.

How do I get the full Form 483 for TriRx Huntsville Pharmaceutical Services, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free